title: A mutation in the start codon of γ-crystallin D leads to nuclear cataracts in the Dahl SS/Jr-Ctr strain.
abstract: Cataracts are a major cause of blindness. The most common forms of cataracts are age- and UV-related and develop mostly in the elderly, while congenital cataracts appear at birth or in early childhood. The Dahl salt-sensitive (SS/Jr) rat is an extensively used model of salt-sensitive hypertension that exhibits concomitant renal disease. In the mid-1980s, cataracts appeared in a few animals in the Dahl S colony, presumably the result of a spontaneous mutation. The mutation was fixed and bred to establish the SS/Jr-Ctr substrain. The SS/Jr-Ctr substrain has been used exclusively by a single investigator to study the role of steroids and hypertension. Using a classical positional cloning approach, we localized the cataract gene with high resolution to a less than 1-Mbp region on chromosome 9 using an F1(SS/Jr-Ctr × SHR) × SHR backcross population. The 1-Mbp region contained only 13 genes, including 4 genes from the γ-crystallins (Cryg) gene family, which are known to play a role in cataract formation. All of the γ-crystallins were sequenced and a novel point mutation in the start codon (ATG → GTG) of the Crygd gene was identified. This led to the complete absence of the CRYGD protein in the eyes of the SS/Jr-Ctr strain. In summary, the identification of the genetic cause in this novel cataract model may provide an opportunity to better understand the development of cataracts, particularly in the context of hypertension.
authors: Department of Pharmacology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
authors: Ashley C
authors: AC
authors: Johnson
authors: Jonathan W
authors: JW
authors: Lee
authors: Ashlyn C
authors: AC
authors: Harmon
authors: Zaliya
authors: Z
authors: Morris
authors: Xuexiang
authors: X
authors: Wang
authors: Jonathan
authors: J
authors: Fratkin
authors: John P
authors: JP
authors: Rapp
authors: Elise
authors: E
authors: Gomez-Sanchez
authors: Michael R
authors: MR
authors: Garrett
mesh_terms: D000818:Animals; D002386:Cataract / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D003001:Cloning, Molecular; D018387:Codon, Initiator / Q000235:genetics*; D005260:Female; D008040:Genetic Linkage; D005838:Genotype; D006973:Hypertension / Q000235:genetics; D008297:Male; D009154:Mutation; D040641:Quantitative Trait Loci; D051381:Rats; D011918:Rats, Inbred SHR; D017422:Sequence Analysis, DNA; D038222:gamma-Crystallins / Q000235:genetics*
chemical_list: D018387:Codon, Initiator; D038222:gamma-Crystallins
references: Cell Growth Differ. 2002 Jul;13(7):297-305
references: 12133898
references: Exp Eye Res. 2009 Feb;88(2):173-89
references: 19007775
references: Biol Pharm Bull. 2008 Nov;31(11):1990-5
references: 18981561
references: Pathol Int. 2005 Nov;55(11):732-7
references: 16271086
references: Hum Mol Genet. 2009 Aug 1;18(15):2825-38
references: 19423552
references: J Am Soc Nephrol. 2003 Feb;14(2):516-29
references: 12538754
references: Mamm Genome. 2002 Aug;13(8):452-5
references: 12226711
references: J Biol Chem. 2011 Dec 23;286(51):43891-43901
references: 21949186
references: Philos Trans R Soc Lond B Biol Sci. 2011 Apr 27;366(1568):1278-92
references: 21402586
references: Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2255-61
references: 10892870
references: Biochem Biophys Res Commun. 2005 Feb 18;327(3):837-44
references: 15649421
references: Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):884-9
references: 9023351
references: Mol Vis. 2008 May 07;14:823-8
references: 18470322
references: Exp Physiol. 2010 Jan;95(1):120-30
references: 19837774
references: J Am Soc Nephrol. 2011 Jun;22(6):1031-40
references: 21597036
references: Biol Chem. 1997 Nov;378(11):1331-48
references: 9426193
references: Philos Trans R Soc Lond B Biol Sci. 2011 Apr 27;366(1568):1234-49
references: 21402583
references: Genomics. 1996 Aug 15;36(1):171-3
references: 8812430
references: Eye (Lond). 1999 Jun;13 ( Pt 3b):480-3
references: 10627828
references: Hypertension. 2006 Nov;48(5):804-11
references: 17015783
references: Genetics. 2006 Jul;173(3):1649-63
references: 16585135
references: Physiol Genomics. 2007 Aug 20;30(3):322-34
references: 17504948
references: Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):173-8
references: 17896293
references: Clin Exp Pharmacol Physiol. 2012 Jan;39(1):90-5
references: 21585422
references: Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3004-10
references: 16799046
references: Bioessays. 1997 Sep;19(9):755-65
references: 9297966
references: Physiol Genomics. 2006 Mar 13;25(1):39-49
references: 16534143
references: Hypertension. 2012 Nov;60(5):1157-68
references: 22987919
references: Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3719-28
references: 17652744
references: Invest Ophthalmol Vis Sci. 1987 Aug;28(8):1422-8
references: 3610557
references: J Am Soc Nephrol. 2011 Aug;22(8):1403-15
references: 21372206
references: EMBO J. 2002 Nov 15;21(22):6005-14
references: 12426373
references: Genome Res. 1998 Jul;8(7):711-23
references: 9685318
references: Hypertension. 1985 May-Jun;7(3 Pt 1):340-9
references: 3997219
references: Nat Genet. 1998 Sep;20(1):92-5
references: 9731540
references: J Genet. 2009 Dec;88(4):469-86
references: 20090208
references: Prog Retin Eye Res. 2007 Jan;26(1):78-98
references: 17166758
references: Steroids. 1996 Apr;61(4):184-8
references: 8732997
references: Mamm Genome. 2001 Mar;12(3):207-11
references: 11252169
references: Genomics. 2000 Feb 1;63(3):314-20
references: 10704279
references: J Am Soc Nephrol. 2000 Nov;11 Suppl 16:S106-15
references: 11065340
references: Am J Public Health. 2008 Mar;98(3):454-61
references: 18235074
references: Physiol Res. 2012;61(Suppl 1):S35-S87
references: 22827876
references: Am J Ophthalmol. 2012 Dec;154(6 Suppl):S23-30.e1
references: 22633355
references: J Am Soc Nephrol. 2003 May;14(5):1175-87
references: 12707388
references: Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2924-34
references: 11687538
references: Eur J Med Genet. 2010 Nov-Dec;53(6):347-57
references: 20624502